These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28667090)

  • 1. Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells.
    Piras F; Riba M; Petrillo C; Lazarevic D; Cuccovillo I; Bartolaccini S; Stupka E; Gentner B; Cittaro D; Naldini L; Kajaste-Rudnitski A
    EMBO Mol Med; 2017 Sep; 9(9):1198-1211. PubMed ID: 28667090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Impact of Cyclosporin A on Lentiviral Transduction and Preservation of Human Hematopoietic Stem Cells in Clinically Relevant
    Petrillo C; Calabria A; Piras F; Capotondo A; Spinozzi G; Cuccovillo I; Benedicenti F; Naldini L; Montini E; Biffi A; Gentner B; Kajaste-Rudnitski A
    Hum Gene Ther; 2019 Sep; 30(9):1133-1146. PubMed ID: 31037976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin a and rapamycin relieve distinct lentiviral restriction blocks in hematopoietic stem and progenitor cells.
    Petrillo C; Cesana D; Piras F; Bartolaccini S; Naldini L; Montini E; Kajaste-Rudnitski A
    Mol Ther; 2015 Feb; 23(2):352-62. PubMed ID: 25270076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells.
    Valeri E; Unali G; Piras F; Abou-Alezz M; Pais G; Benedicenti F; Lidonnici MR; Cuccovillo I; Castiglioni I; Arévalo S; Spinozzi G; Merelli I; Behrendt R; Oo A; Kim B; Landau NR; Ferrari G; Montini E; Kajaste-Rudnitski A
    Mol Ther; 2024 Jan; 32(1):124-139. PubMed ID: 37990494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders.
    Tucci F; Galimberti S; Naldini L; Valsecchi MG; Aiuti A
    Nat Commun; 2022 Mar; 13(1):1315. PubMed ID: 35288539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem Cells.
    Masiuk KE; Brown D; Laborada J; Hollis RP; Urbinati F; Kohn DB
    Mol Ther; 2017 Sep; 25(9):2163-2175. PubMed ID: 28663101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular innate immunity and restriction of viral infection: implications for lentiviral gene therapy in human hematopoietic cells.
    Kajaste-Rudnitski A; Naldini L
    Hum Gene Ther; 2015 Apr; 26(4):201-9. PubMed ID: 25808164
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Rajawat YS; Humbert O; Cook SM; Radtke S; Pande D; Enstrom M; Wohlfahrt ME; Kiem HP
    Hum Gene Ther; 2021 Jan; 32(1-2):113-127. PubMed ID: 32741228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A.
    Doering CB; Denning G; Shields JE; Fine EJ; Parker ET; Srivastava A; Lollar P; Spencer HT
    Hum Gene Ther; 2018 Oct; 29(10):1183-1201. PubMed ID: 30160169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans.
    Scala S; Basso-Ricci L; Dionisio F; Pellin D; Giannelli S; Salerio FA; Leonardelli L; Cicalese MP; Ferrua F; Aiuti A; Biasco L
    Nat Med; 2018 Nov; 24(11):1683-1690. PubMed ID: 30275570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E
    Heffner GC; Bonner M; Christiansen L; Pierciey FJ; Campbell D; Smurnyy Y; Zhang W; Hamel A; Shaw S; Lewis G; Goss KA; Garijo O; Torbett BE; Horton H; Finer MH; Gregory PD; Veres G
    Mol Ther; 2018 Jan; 26(1):320-328. PubMed ID: 29102562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells.
    Barclay SL; Yang Y; Zhang S; Fong R; Barraza A; Nolta JA; Torbett BE; Abedi M; Bauer G; Anderson JS
    Stem Cells; 2015 Mar; 33(3):870-9. PubMed ID: 25524029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Answered and Unanswered Questions in Early-Stage Viral Vector Transduction Biology and Innate Primary Cell Toxicity for
    Dudek AM; Porteus MH
    Front Immunol; 2021; 12():660302. PubMed ID: 34122418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.
    Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A
    Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible gene and shRNA expression in resident hematopoietic stem cells in vivo.
    Laurenti E; Barde I; Verp S; Offner S; Wilson A; Quenneville S; Wiznerowicz M; Macdonald HR; Trono D; Trumpp A
    Stem Cells; 2010 Aug; 28(8):1390-8. PubMed ID: 20641037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the mammalian target of rapamycin pathway in lentiviral vector transduction of hematopoietic stem cells.
    Wang CX; Torbett BE
    Curr Opin Hematol; 2015 Jul; 22(4):302-8. PubMed ID: 26049750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapy.
    Baldwin K; Urbinati F; Romero Z; Campo-Fernandez B; Kaufman ML; Cooper AR; Masiuk K; Hollis RP; Kohn DB
    Stem Cells; 2015 May; 33(5):1532-42. PubMed ID: 25588820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Clinical Ex Vivo Hematopoietic Stem Cell Gene Therapy for Inherited Monogenic Diseases.
    Tucci F; Scaramuzza S; Aiuti A; Mortellaro A
    Mol Ther; 2021 Feb; 29(2):489-504. PubMed ID: 33221437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Engraftment of Lentiviral Vector-Transduced Human CD34+ Cells into Humanized Mice.
    Kim YS; Wielgosz M; Ryu B
    Methods Mol Biol; 2019; 2005():91-100. PubMed ID: 31175648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.